SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called GI-101, either alone or with pembrolizumab or lenvatinib, in people with advanced solid tumors (cancers that have spread). The goal is to see if it is safe and works against the cancer. About 317 adults with certain cancers like lung, kidney, or…
Matched conditions: SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated May 17, 2026 02:45 UTC
-
New drug ABBV-324 enters first human tests for tough cancers
Disease control Recruiting nowThis early-phase study tests an experimental drug called ABBV-324 in about 232 adults with liver cancer (hepatocellular carcinoma) or a type of lung cancer (squamous non-small cell lung cancer). The main goals are to check safety, side effects, and whether the drug shrinks tumors…
Matched conditions: SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug ZW251 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called ZW251 in people with advanced liver cancer, a type of lung cancer, or certain germ cell tumors. The drug is designed to seek out and attack cancer cells while sparing healthy ones. The main goals are to check safety and find the righ…
Matched conditions: SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Zymeworks BC Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC